INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 48m ago
House PTR8m ago
SEC 13F7m ago
Robinhood Chain7m ago

Most active filers · 30d

  1. 01Kurtz George0B / 215S215 trades$52.62M
  2. 02FWFogarty Patrick W0B / 150S150 trades$600K
  3. 03SPSaba Capital Management, L.P.65B / 19S · 11 late84 trades$21.64M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07SJSheena Jonathan0B / 45S45 trades$3.01M
  8. 08SISarowitz Steven I2B / 34S36 trades$22.46M
  9. 09SLSpeiser Michael L0B / 35S35 trades$14.00M
  10. 10RARothblatt Martine A0B / 33S33 trades$5.50M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 1732 insiders$917K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 168 insiders$42.58M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  7. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  8. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M

Form 4 transactions

72,525 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
Farquhar ScottDirector, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$447K
3,214 sh
Jan 13, 2026
Page 1487 of 1814
← PrevNext →
Jan 14, 2026
traded Jan 13, 2026
+1d
SEC Form 4

Evidence

9
CR
Corbett RyanChief Financial Officer
MPMP Materials Corp. / DE
Grant or award
A—
16.6K sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

9
AJ
Adams Raymond John IIIPresident
HPHelmerich & Payne, Inc.
Grant or award
A—
2,004 sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

9
HM
Hair Cara M.SVP, CORP. SERVICES & CLO
HPHelmerich & Payne, Inc.
Tax withholding
F$32K
1,045 sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

9
NP
Nolan Sean P.Director, Chief Executive Officer
TSHATaysha Gene Therapies, Inc.
Grant or award
A—
648.0K sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

9
DM
Dondzila Catherine MChief Accounting Officer
FRGEForge Global Holdings, Inc.
Tax withholding
F—
666 sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

9
BG
Birkenbeuel GaryDirector
TTEKTETRA TECH INC
Option exercise
M—
1,590 sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

9
OM
Oelschlager Kristen MChief Operating Officer
CSTLCASTLE BIOSCIENCES INC
Grant or award
A—
9,207 sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

9
SJ
Smith Brian JDirector
LKFNLAKELAND FINANCIAL CORP
Grant or award
A—
650 sh
Jan 13, 2026Jan 14, 2026
traded Jan 13, 2026
+1dSEC Form 4

Evidence

9
LA
Lufkin Paul AndrewSenior Vice President, Sales
BYNDBEYOND MEAT, INC.
Tax withholding
F$1,291
1,314 sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

9
BA
Burkhart John A IIIPresident, US P&C, Skyward Grp
SKWDSkyward Specialty Insurance Group, Inc.
Option exercise
M—
6,665 sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

9
BP
Bodnar Dan PKChief Information Officer
SKWDSkyward Specialty Insurance Group, Inc.
Option exercise
M—
5,000 sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

9
AJ
Adams Raymond John IIIPresident
HPHelmerich & Payne, Inc.
Tax withholding
F$21K
684 sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

9
BA
Burkhart John A IIIPresident, US P&C, Skyward Grp
SKWDSkyward Specialty Insurance Group, Inc.
Option exercise
M—
6,665 sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

9
RS
Rosenthal Michael StuartChief Operating Officer
MPMP Materials Corp. / DE
Grant or award
A—
33.6K sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

9
LM
Lennox MichaelEVP, WESTERN HEMISPHERE LAND
HPHelmerich & Payne, Inc.
Tax withholding
F$25K
831 sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

9
RS
Rosenthal Michael StuartChief Operating Officer
MPMP Materials Corp. / DE
Grant or award
A—
18.3K sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

9
IG
Infuso David GregoryChief Accounting Officer
MPMP Materials Corp. / DE
Tax withholding
F$38K
581 sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

9
DP
Duffy Sean P.Director, Chief Executive Officer
OMDAOmada Health, Inc.
Option exercise
M—
230.5K sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

9
DR
Duchscher ReedDirector
FNKOFunko, Inc.
Grant or award
A—
14.3K sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

9
BR
Bell John R.EVP, EASTERN HEMISPHERE LAND
HPHelmerich & Payne, Inc.
Tax withholding
F$27K
874 sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

9
BG
Birkenbeuel GaryDirector
TTEKTETRA TECH INC
Option exercise
M—
1,590 sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

9
RE
Ritrievi Kimberly EDirector
TTEKTETRA TECH INC
Grant or award
A—
2,208 sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

8
IC
Indelicarto Thomas CEVP, Gen Counsel & Secretary
VRSNVERISIGN INC/CA
Open-market sale · 10b5-1 plan
SELL$82K
332 sh
Jan 13, 2026Jan 14, 2026
traded Jan 13, 2026
+1dSEC Form 4

Evidence

8
BA
Bergman ArturDirector, Chief Technology Officer
FSLYFastly, Inc.
Open-market sale · 10b5-1 plan
SELL$187K
20.0K sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

8
CR
Corbett RyanChief Financial Officer
MPMP Materials Corp. / DE
Tax withholding
F$243K
3,511 sh
Jan 14, 2026Jan 14, 2026
traded Jan 14, 2026
+0dSEC Form 4

Evidence

8
MJ
Murry Stefan J.Chief Financial Officer
AAOIAPPLIED OPTOELECTRONICS, INC.
Open-market sale · 10b5-1 plan
SELL$101K
3,000 sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

7
LF
Lo FrancisChief People Officer
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M—
36.6K sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

7
DK
DeHoff KateSee Remarks
JOBYJoby Aviation, Inc.
Option exercise · 10b5-1 plan
M—
16.1K sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

7
SD
Spector DavidDirector, Chairman & CEO
PFSIPennyMac Financial Services, Inc.
Open-market sale · 10b5-1 plan
SELL$706K
4,872 sh
Jan 13, 2026Jan 14, 2026
traded Jan 13, 2026
+1dSEC Form 4

Evidence

7
NS
Nagendran SukumarDirector, President and Head of R&D
TSHATaysha Gene Therapies, Inc.
Grant or award · 10b5-1 plan
A—
427.0K sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

7
SD
Spector DavidDirector, Chairman & CEO
PFSIPennyMac Financial Services, Inc.
Open-market sale · 10b5-1 plan
SELL$739K
5,080 sh
Jan 13, 2026Jan 14, 2026
traded Jan 13, 2026
+1dSEC Form 4

Evidence

7
NS
Nagendran SukumarDirector, President and Head of R&D
TSHATaysha Gene Therapies, Inc.
Option exercise · 10b5-1 plan
M—
88.7K sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

7
PK
Piskel KyleChief Financial Officer
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M—
4,290 sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

7
BG
Bowles GregoryChief Policy Officer
JOBYJoby Aviation, Inc.
Option exercise · 10b5-1 plan
M—
2,607 sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

6
CM
Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$84K
600 sh
Jan 13, 2026Jan 14, 2026
traded Jan 13, 2026
+1dSEC Form 4

Evidence

6
NS
Nagendran SukumarDirector, President and Head of R&D
TSHATaysha Gene Therapies, Inc.
Option exercise · 10b5-1 plan
M$152K
88.7K sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

6
Farquhar ScottDirector, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$51K
350 sh
Jan 13, 2026Jan 14, 2026
traded Jan 13, 2026
+1dSEC Form 4

Evidence

6
NS
Nagendran SukumarDirector, President and Head of R&D
TSHATaysha Gene Therapies, Inc.
Option exercise · 10b5-1 plan
M$78K
111.3K sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

6
TP
Tuffin PaulaGeneral Counsel and CCO
BETRBetter Home & Finance Holding Co
Open-market sale · 10b5-1 plan
SELL$12K
302 sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence